IL107025A0 - Recombinant multivalent m protein vaccine - Google Patents

Recombinant multivalent m protein vaccine

Info

Publication number
IL107025A0
IL107025A0 IL107025A IL10702593A IL107025A0 IL 107025 A0 IL107025 A0 IL 107025A0 IL 107025 A IL107025 A IL 107025A IL 10702593 A IL10702593 A IL 10702593A IL 107025 A0 IL107025 A0 IL 107025A0
Authority
IL
Israel
Prior art keywords
protein vaccine
recombinant multivalent
vaccine
recombinant
evoke
Prior art date
Application number
IL107025A
Other languages
English (en)
Original Assignee
Univ Tennessee Res Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tennessee Res Corp filed Critical Univ Tennessee Res Corp
Publication of IL107025A0 publication Critical patent/IL107025A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL107025A 1992-09-16 1993-09-15 Recombinant multivalent m protein vaccine IL107025A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94595492A 1992-09-16 1992-09-16

Publications (1)

Publication Number Publication Date
IL107025A0 true IL107025A0 (en) 1993-12-28

Family

ID=25483752

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107025A IL107025A0 (en) 1992-09-16 1993-09-15 Recombinant multivalent m protein vaccine

Country Status (10)

Country Link
US (1) US6063386A (fr)
EP (1) EP0625043B1 (fr)
AT (1) ATE214601T1 (fr)
AU (1) AU5128493A (fr)
CA (1) CA2123579C (fr)
DE (1) DE69331733T2 (fr)
DK (1) DK0625043T3 (fr)
ES (1) ES2170075T3 (fr)
IL (1) IL107025A0 (fr)
WO (1) WO1994006421A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
AU5128593A (en) * 1992-09-16 1994-04-12 University Of Tennessee Research Corporation, The Antigen of hybrid m protein and carrier for group a streptococcal vaccine
EP0625043B1 (fr) * 1992-09-16 2002-03-20 The University Of Tennessee Research Corporation Vaccin a proteine m multivalente recombinee
AU3651595A (en) * 1994-09-21 1996-04-09 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Drug for the prevention and treatment of auto-immune and viral diseases, and diagnostic agents for detecting said diseases
AUPM885194A0 (en) * 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
US6287574B1 (en) * 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
US5846547A (en) * 1996-01-22 1998-12-08 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
US6355255B1 (en) 1998-12-07 2002-03-12 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
EP1801217A1 (fr) * 1997-09-12 2007-06-27 The University of Tennessee Research Foundation Groupement de vaccins streptococciques
EP1003875B1 (fr) * 1997-09-12 2006-12-27 University of Tennessee Research Foundation Vaccin a base de streptocoques du groupe a
US6716433B1 (en) 1997-09-12 2004-04-06 University Of Tennessee Research Foundation Group a streptococcal vaccines
US6541011B2 (en) * 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
AU762100B2 (en) * 1998-12-22 2003-06-19 University Of Tennessee Research Corporation, The Protective antigen of group A Streptococci (SPA)
US7063850B1 (en) 1998-12-22 2006-06-20 University Of Tennessee Research Foundation Protective antigen of group A Streptococci
US7256265B2 (en) 1999-12-03 2007-08-14 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
DK1294771T3 (da) * 2000-06-12 2008-12-15 Univ Saskatchewan Kimært GapC-protein fra Streptococcus og anvendelse deraf til vaccinering og diagnosticering
US7160547B2 (en) 2000-10-10 2007-01-09 University Of Tennessee Research Corporation Streptococcal streptolysin S vaccines
WO2002057315A2 (fr) * 2000-10-10 2002-07-25 University Of Tennessee Research Corporation Vaccins anti-streptocoques à base de streptolysine s
EP2025754A3 (fr) * 2001-05-15 2009-05-13 ID Biomedical Corporation Antigènes de Moraxella (Branhamella) catarrhalis
AU2011232787B2 (en) * 2001-05-18 2013-05-02 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention, Technology Transfer Office Peptide vaccines against group A streptococci
AU2008203277B2 (en) * 2001-05-18 2011-07-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention, Technology Transfer Office Peptide vaccines against group A streptococci
CA2881980A1 (fr) 2001-05-18 2002-11-28 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention, Technology Transfer Office Vaccins peptidiques contre les streptocoques du groupe a
AU2002365184A1 (en) 2001-10-26 2003-07-30 Id Biomedical Corporation Of Washington Efficient protein expression system
EP1572941A4 (fr) 2002-02-26 2009-03-18 Maxygen Inc Nouveaux antigenes de flavivirus
US7255867B2 (en) * 2002-11-15 2007-08-14 Id Biomedical Corporation Of Quebec Vaccine
US20040151737A1 (en) * 2003-02-05 2004-08-05 University Of Tennessee Streptococcal serum opacity factors and fibronectin-binding proteins and peptides thereof for the treatment and detection of streptococcal infection
US20070110763A1 (en) * 2003-08-15 2007-05-17 Stephane Rioux Polypeptides of streptococcus pyogenes
EP1864996A1 (fr) * 2006-06-06 2007-12-12 Helmholtz-Zentrum für Infektionsforschung GmbH Peptide associé de la fievre rhumatismale et son utilisation comme marquer diagnostique.
US9289485B2 (en) * 2006-11-30 2016-03-22 Luiza Guilherme Guglielmi Therapeutic application of S. pyogenes C-terminal peptide
BRPI0604997A (pt) * 2006-11-30 2007-05-22 Fundacao Zerbini vacina contra o estreptococo beta hemolìtico do grupo a, e respectivo processo de obtenção
EP2144924B1 (fr) * 2007-04-16 2016-05-11 MinervaX Aps Vaccin à protéine de fusion
BRPI0815008B8 (pt) * 2007-08-02 2021-05-25 Biondvax Pharmaceuticals Ltd vacinas multiméricas com múltiplos epítopos contra influenza
AR074273A1 (es) 2008-11-05 2011-01-05 Wyeth Corp Composicion inmunigenica de multiples componentes para la prevencion de la enfermedad estreptococica beta-hemolitica bhs. uso. metodo
AU2011360572B2 (en) 2011-02-22 2017-03-02 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
CN103648526A (zh) 2011-06-17 2014-03-19 田纳西大学研究基金会 A群链球菌多价疫苗
US9650425B2 (en) 2013-02-11 2017-05-16 University Of Tennessee Research Foundation Group A streptococcal M-related proteins and methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284537A (en) * 1980-07-03 1981-08-18 The United States Of America As Represented By The Department Of Health And Human Services Conjugate of streptococcal M protein peptide vaccine
US4454121A (en) * 1982-07-27 1984-06-12 The University Of Tennessee Research Corporation Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes
US4597967A (en) * 1982-07-27 1986-07-01 The University Of Tennessee Research Corp. Synthetic polypeptide fragments
US4521334A (en) * 1982-07-27 1985-06-04 The University Of Tennesse Research Corporation Synthetic polypeptide fragments
US4919930A (en) * 1983-06-10 1990-04-24 University Of Tennessee Research Corporation Synthetic M proteins-streptococci type 5
US4784948A (en) * 1983-08-10 1988-11-15 The Rockefeller University Production of streptococcal m protein immunogens and molecular probes
US4705684A (en) * 1985-05-31 1987-11-10 The University Of Tennessee Research Corporation Synthetic M proteins - streptococci type 6
US5124153A (en) * 1987-08-24 1992-06-23 University Of Tennessee Research Corp. Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
WO1993021220A1 (fr) * 1992-04-08 1993-10-28 The Council Of The Queensland Institute Of Medical Research Peptides synthetiques utilises dans un vaccin contre l'infection par les streptocoques et pour le diagnostic de cette infection
EP0625043B1 (fr) * 1992-09-16 2002-03-20 The University Of Tennessee Research Corporation Vaccin a proteine m multivalente recombinee

Also Published As

Publication number Publication date
EP0625043A4 (en) 1997-05-21
ES2170075T3 (es) 2002-08-01
DK0625043T3 (da) 2002-04-22
CA2123579A1 (fr) 1994-03-31
CA2123579C (fr) 2005-05-10
AU5128493A (en) 1994-04-12
DE69331733T2 (de) 2002-08-22
WO1994006421A1 (fr) 1994-03-31
EP0625043B1 (fr) 2002-03-20
EP0625043A1 (fr) 1994-11-23
DE69331733D1 (de) 2002-04-25
ATE214601T1 (de) 2002-04-15
US6063386A (en) 2000-05-16

Similar Documents

Publication Publication Date Title
EP0625043A4 (en) Recombinant multivalent m protein vaccine.
DK0618813T3 (da) Antigen for M-hybridprotein og bærer for gruppe A streptococcal vaccine
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
DE3853454D1 (de) Therapeutische Zusammensetzungen gegen Streptokokken-Infektionen, transformierte Wirte, Verfahren zur Immunisierung und gentechnologisch hergestellte Produkte.
CA2131729A1 (fr) Proteines de l'helicobacter pylori pouvant servir a la production de vaccins et pour le diagnostic
ATE132195T1 (de) Rekombinant-mykobakterielle impfstoffe
AR029322A1 (es) Un polinucleotido de estreptococo aislado que codifica un polipeptido capaz de generar anticuerpos que tienen especificidad de union para un segundo polipeptido de secuencias reveladas, los polipeptidos mencionados y un proceso para su fabricacion, un polipeptido quimerico, compuesto por dichos segu
HUP9901546A2 (hu) Helicobacter pylori antigének és vakcinakészítmények
WO2003065973A8 (fr) Compositions de vaccins multivalents a base de streptocoques et procedes d'utilisation
ATE359370T1 (de) Heterologe antigene in stämmen zur impfung mit lebendzellen
NO20011381L (no) Preparater av streptokokk C<beta>-protein
ES2000255A6 (es) Un metodo para sintetizar al menos una porcion de toxina del tetanos o un peptido que comprende al menos un epitopo de la misma.
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
FI902569A0 (fi) Producering av till gonorre anslutande pi-proteiner och vaccin.
DK1274853T3 (da) Materialer og fremgangsmåder, der angår immunreaktioner på fusionsproteiner
DK0499681T3 (da) pCTD-plasmid isoleret fra Chlamydia trachomatis serotype D, dets gener og proteiner, som kodes af dem; rekombinante plasmid
EP0691404A3 (fr) Vaccins améliorés pour l'immunisation contre l'encéphalite virale de la tique (TBE-virus) et méthode de fabrication
NZ331889A (en) Trypanosomatids histones for use as an antigen against trypanosomatic infection, including diagnostic tests, pharmaceutical compositions and vaccines of these antigens
NZ512308A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
ES2088371A1 (es) Procedimiento para la produccion en forma recombinante de antigenos de la glicoproteina ge de herpesvirus bovino tipo 1 y su uso en la diferenciacion serologica entre animales infectados y animales vacunados.